$39.00
Manufacturer: Italy
Treatment and prevention of intestinal dysbiosis and associated endogenous dysvitaminosis. Therapy aimed at restoring the normal intestinal microflora, which is disturbed during treatment with antibiotics or chemotherapy drugs. Acute and chronic gastrointestinal diseases associated with intoxication or intestinal dysbiosis and dysvitaminosis in infants who are fed breast milk.
Description
Enterogermina forte Composition
active substance: spores of a multi-resistant strain of Bacillus clausii;
1 bottle of 5 ml contains spores of the multidrug-resistant Bacillus clausii strain 4 × 109;
auxiliary substances: purified water.
Enterogermina forte Dosage form
Oral suspension.
Basic physical and chemical properties: whitish opalescent liquid.
Enterogermina forte Pharmacological group
Antidiarrheal microbial drugs.
ATX code A07F A.
Pharmacological properties
Pharmacodynamics.
Enterojermina® Forte is a suspension of Bacillus clausii spores, which are usually present in the intestine and do not show pathogenic activity.
In addition, due to the ability of Bacillus clausii to synthesize various vitamins, especially of group B, the drug helps to correct dysvitaminosis caused by the use of antibiotics or chemotherapy drugs. Due to the metabolic activity of Bacillus clausii, the use of the drug makes it possible to achieve a nonspecific antigenic and antitoxic effect.
Due to their high resistance to chemical and physical agents, spores of Bacillus clausii pass unharmed through the gastric juice barrier into the intestinal tract, where they are converted into metabolically active vegetative cells.
Pharmacokinetics.
There is no data.
Indications
Treatment and prevention of intestinal dysbiosis and associated endogenous dysvitaminosis.
Adjunctive therapy aimed at restoring normal intestinal microflora is disrupted during treatment with antibiotics or chemotherapy drugs.
Acute and chronic gastrointestinal diseases in infants associated with intoxication or intestinal dysbiosis and dysvitaminosis.
Contraindications
Hypersensitivity to the active substance or to any of the excipients of the drug.
Special security measures
Vials with Enterogermina® Forte may contain visible particles formed as a result of aggregation of spores of Bacillus clausii and do not indicate that the drug has undergone any changes.
Shake the bottle before use.
The drug has a high degree of heterologous resistance to antibiotics, which makes it possible to use it both for the prevention of changes in the intestinal microflora caused by the selective action of antibiotics (especially broad-spectrum antibiotics) and for the restoration of an already disturbed balance of the intestinal microflora.
The drug does not interact with such antibiotics: penicillin when used not in combination with beta-lactamase inhibitors, cephalosporins (partial resistance in most cases), tetracycline, macrolides, aminoglycosides (with the exception of gentamicin and amikacin), chloramphenicol, thiamphenicol, lincomycin, isoniazidamide , cycloserine, novobiocin, rifampicin, nalidixic acid and pipemidic acid (intermediate resistance), metronidazole.
If the drug is given concurrently with antibiotics, it should be used between two antibiotic doses.
This medicinal product is intended for oral use only. It is forbidden to inject the drug by injection or any other way. Inappropriate use of this drug has resulted in severe anaphylactic reactions such as anaphylactic shock.
Recent Reviews